In addition, the benefits from NMN were abolished by Eva1c knockdown (Fig. 6B), possibly due to a big variation in the performance of the animals (Fig. 6B), while Eva1c knockdown blocked the beneficial effects of NMN treatment in Tauopathy, supporting the mechanistic results presented in Fig. 7F. This evidence concerns the gene EVA1C and tauopathy.